Search
for
Sort by
Research 721–750 of 1000+
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Alopecia areata update
- Alopecia Areata
- Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial
- Treatment of pediatric alopecia areata: A systematic review
- Scalp bacterial shift in Alopecia areata
- Alopecia areata and the gut—the link opens up for novel therapeutic interventions
- Increased prevalence of vitamin D deficiency in patients with alopecia areata: a systematic review and meta‐analysis
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata
- Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata
- Alopecia Areata: Treatment of Today and Tomorrow
- Treatment of widespread alopecia areata in young patients with monthly oral corticosteroid pulse.
- TREATMENT OF ALOPECIA AREATA
- Management of alopecia areata: Updates and algorithmic approach
- New and Emerging Therapies for Alopecia Areata
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Serological screening for coeliac disease in vitiligo and alopecia areata
- Alopecia Areata in Korea (1982–1994)
- Treatment-Resistant Alopecia Areata
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata
- Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata
- Quality of Life in Alopecia Areata: A Sample of Tunisian Patients
- Topical immunotherapy in alopecia areata
- Treatment of persistent alopecia areata with sulfasalazine
- Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety